Not available
Quote | Soleno Therapeutics Inc. (NASDAQ:SLNO)
Last: | $40.14 |
---|---|
Change Percent: | 0.83% |
Open: | $37.23 |
Close: | $40.14 |
High: | $40.525 |
Low: | $37.23 |
Volume: | 416,658 |
Last Trade Date Time: | 04/23/2024 03:00:00 am |
News | Soleno Therapeutics Inc. (NASDAQ:SLNO)
2024-03-07 10:01:04 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Waters, Moderna most shorted ...
2024-03-06 16:47:28 ET More on Soleno Therapeutics Soleno Therapeutics And Acadia Pharmaceuticals: Hope For Prader-Willi Families Seeking Alpha’s Quant Rating on Soleno Therapeutics Historical earnings data for Soleno Therapeutics Financial information...
Message Board Posts | Soleno Therapeutics Inc. (NASDAQ:SLNO)
Subject | By | Source | When |
---|---|---|---|
RMB They almost have this fully enrolled ( | Whalatane | investorshub | 04/04/2023 11:01:04 PM |
whytestocks: $SLNO News Article - Soleno Therapeutics Provides Corporate Update and Reports Fourth Q | whytestocks | investorshangout | 03/21/2023 8:40:52 PM |
whytestocks: $SLNO News Article - Soleno Therapeutics to Participate in the Oppenheimer 33rd Annual | whytestocks | investorshangout | 03/07/2023 1:05:45 PM |
$SLNO....................https://stockcharts.com/h-sc/ui?s=$SLNO&p=W&b=5&g=0&id=p8 | glenn1919 | investorshub | 02/10/2023 9:06:16 PM |
New peer reviewed article | Whalatane | investorshub | 01/26/2023 4:00:03 PM |
News, Short Squeeze, Breakout and More Instantly...
Soleno Therapeutics Inc. Company Name:
SLNO Stock Symbol:
NASDAQ Market:
REDWOOD CITY, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today provided a corporate update, and reported financial results for the fourth...
REDWOOD CITY, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. ("Soleno") (NASDAQ:SLNO), a clinical-stage biopharmaceutical c...
Soleno Therapeutics, Inc. (NASDAQ: SLNO) is the focus of IBN's latest stock spotlight. The company's shares have moved 2.83% on the day to $48.66. Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for t...